ARDS, HUMAN
Clinical trials for ARDS, HUMAN explained in plain language.
Never miss a new study
Get alerted when new ARDS, HUMAN trials appear
Sign up with your email to follow new studies for ARDS, HUMAN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New care pathway aims to save lives of ICU patients with lung failure
Disease control OngoingThis study tests a step-by-step care plan for patients with severe breathing failure (ARDS) who need a breathing machine. The plan uses proven treatments like protective ventilation, paralysis, and prone positioning. Researchers will see if following this plan helps patients surv…
Matched conditions: ARDS, HUMAN
Phase: NA • Sponsor: University of Calgary • Aim: Disease control
Last updated May 26, 2026 05:53 UTC
-
Abandoned trial: thyroid hormone spray for COVID lungs never tested
Disease control TerminatedThis study aimed to test a thyroid hormone (T3) treatment sprayed directly into the lungs of COVID-19 patients with severe breathing failure (ARDS) who were on ventilators. The goal was to reduce lung fluid and improve recovery. However, the trial was withdrawn before any patient…
Matched conditions: ARDS, HUMAN
Phase: PHASE2 • Sponsor: University of Minnesota • Aim: Disease control
Last updated May 26, 2026 05:51 UTC
-
Stem cell trial for COVID lung damage halted before start
Disease control TerminatedThis study aimed to test a stem cell treatment for people recovering from severe COVID-19 lung problems. The treatment used donor stem cells to help repair lung damage. However, the study was withdrawn before any participants were enrolled.
Matched conditions: ARDS, HUMAN
Phase: PHASE1 • Sponsor: BioCardia, Inc. • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
Could a thyroid hormone help ARDS patients breathe easier?
Disease control OngoingThis study tests whether giving a thyroid hormone (T3) directly into the lungs is safe and can improve oxygen levels in adults with acute respiratory distress syndrome (ARDS) who are on a ventilator. About 68 critically ill patients will either receive T3 or standard care. The go…
Matched conditions: ARDS, HUMAN
Phase: PHASE2 • Sponsor: University of Minnesota • Aim: Disease control
Last updated May 22, 2026 13:54 UTC